Machine Learning Predictive Modeling for the Identification of Moderate Coronavirus Disease 2019 During the Pandemic:

Tao Wang1, Zhanqing Zhao2, Wenzhe Li3

  • 1Department of Critical Care Medicine, Shanghai General Hospital, Shanghai, CHN.

Cureus
|January 16, 2024
PubMed

Insights

A logistic regression model can predict moderate COVID-19 cases using age, respiratory rate, D-dimer, lactate dehydrogenase, and albumin. This model shows improved accuracy for patients aged 66 years or younger.

Area of Science:

  • Medical research
  • Machine learning in healthcare
  • Infectious disease epidemiology

Background:

  • Differentiating moderate COVID-19 from mild cases is crucial for timely treatment and resource allocation.
  • Predictive models can aid in early identification of patients likely to develop moderate COVID-19.
  • This study aimed to develop and validate a predictive model for moderate COVID-19.

Purpose of the Study:

  • To construct and evaluate machine learning models for predicting moderate COVID-19.
  • To identify key clinical and laboratory factors associated with moderate COVID-19 progression.
  • To select the optimal model for predicting moderate COVID-19 occurrence.

Main Methods:

  • Retrospective study of 231 COVID-19 patients.
  • Data collected included demographics, clinical signs, comorbidities, and laboratory results.
  • Machine learning models (BNB, LDA, SVM, LASSO, LR) were trained and compared using AUC, sensitivity, and specificity.

Main Results:

  • A logistic regression (LR) model incorporating age, respiratory rate, lactate dehydrogenase, D-dimer, and albumin demonstrated predictive capability.
  • The LR model achieved an AUC of 0.719, sensitivity of 0.681, and specificity of 0.635.
  • The model showed enhanced predictive performance in patients aged ≤66 years (AUC = 0.7656).

Conclusions:

  • The developed LR model effectively predicts moderate COVID-19.
  • Key predictors include age, respiratory rate, D-dimer, lactate dehydrogenase, and albumin.
  • The model is particularly useful for predicting moderate COVID-19 in younger patient cohorts (≤66 years).
Abstract